BioAtla, Inc. — Director's Dealing 2022

Sep 16, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioAtla, Inc. (BCAB)
CIK: 0001826892
Period of Report: 2022-09-12

Reporting Person: MCBRINN SYLVIA (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-09-12	Common Stock	P	2000	$8.85	Acquired	2000	Direct
2022-09-13	Common Stock	P	1000	$8.20	Acquired	3000	Direct